Topic 06 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 13 - 15 Topics

cite ad title authors publish year publish time dataset abstract mentions covid pmcid pubmed id doi cord uid topic weight Similarity scispacy Similarity specter
1 Zuniga_2007 Attenuated measles virus as a vaccine vector Zuniga, Armando; Wang, ZiLi; Liniger, Matthias; Hangartner, Lars; Caballero, Michael; Pavlovic, Jovan; Wild, Peter; Viret, Jean Francois; Glueck, Reinhard; Billeter, Martin A.; Naim, Hussein Y. 2007 2007-04-20 None N PMC3707277 17303293.0 10.1016/j.vaccine.2007.01.064 ryychtqa 0.647705 Mühlebach_2016, Mok_H_2012
2 Peruzzi_2009 A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines Peruzzi, Daniela; Dharmapuri, Sridhar; Cirillo, Agostino; Bruni, Bruno Ercole; Nicosia, Alfredo; Cortese, Riccardo; Colloca, Stefano; Ciliberto, Gennaro; La Monica, Nicola; Aurisicchio, Luigi 2009 2009-02-25 PMC N PMC7115565 19162112.0 10.1016/j.vaccine.2008.12.051 u361oua5 0.627562 Singh_2016, Schwartz_2007, Montefiori_2007
3 Bull_2019 Recombinant vector vaccine evolution Bull, James J.; Nuismer, Scott L.; Antia, Rustom 2019 2019-07-19 COMM-USE N PMC6668849 31323032.0 10.1371/journal.pcbi.1006857 ctass7hz 0.626904 Montefiori_2007, Tripp_2014 Bull_2019, Mühlebach_2016, Zuniga_2007, Nuismer_2019
4 Bangari_2006 Development of nonhuman adenoviruses as vaccine vectors Bangari, Dinesh S.; Mittal, Suresh K. 2006 2006-02-13 None N PMC1462960 16297508.0 10.1016/j.vaccine.2005.08.101 v5n1gupw 0.622664 Tatsis_2004 Tatsis_2004, Mittal_2016
5 Bull_2019 Recombinant vector vaccines and within-host evolution James Bull; Scott L. Nuismer; Rustom Antia 2019 2019-02-08 BioRxiv N 10.1101/545087 3vssgben 0.609826 Bull_2019 Bull_2019, Mühlebach_2016, Nuismer_2019, Zuniga_2007
6 Bishop_1988 The release into the environment of genetically engineered viruses, vaccines and viral pesticides Bishop, David H.L. 1988 1988-04-30 PMC N 10.1016/0169-5347(88)90130-9 s1zl9nbb 0.597917 Bishop_1988
7 Mittal_2016 19 Xenogenic Adenoviral Vectors Mittal, Suresh K.; Ahi, Yadvinder S.; Vemula, Sai V. 2016 2016-12-31 PMC N PMC7149625 10.1016/b978-0-12-800276-6.00019-x mxtry60e 0.569062 Bangari_2006 Bangari_2006, Ploquin_2013
8 Liniger_2009 Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses Liniger, Matthias; Zuniga, Armando; Morin, Teldja Neige Azzouz; Combardiere, Behazine; Marty, Rene; Wiegand, Marian; Ilter, Orhan; Knuchel, Marlyse; Naim, Hussein Y. 2009 2009-05-26 PMC N PMC7115622 19200842.0 10.1016/j.vaccine.2009.01.057 uacon432 0.555529 Schwartz_2007, Lv_L_2014 Mok_H_2012, Mühlebach_2016, Jiang_2006, Sawada_2011
9 Roy_S_2007 Rescue of chimeric adenoviral vectors to expand the serotype repertoire Roy, Soumitra; Clawson, David S.; Lavrukhin, Oleg; Sandhu, Arbans; Miller, Jim; Wilson, James M. 2007 2007-04-30 None N PMC1868475 17197043.0 10.1016/j.jviromet.2006.11.022 zceca4c1 0.541514 Mittal_2016, Ertl_2016, Bangari_2006
10 Bolton_2012 Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates Bolton, Diane L.; Santra, Sampa; Swett-Tapia, Cindy; Custers, Jerome; Song, Kaimei; Balachandran, Harikrishnan; Mach, Linh; Naim, Hussein; Kozlowski, Pamela A.; Lifton, Michelle; Goudsmit, Jaap; Letvin, Norman; Roederer, Mario; Radošević, Katarina 2012 2012-09-07 None N PMC3425710 22732429.0 10.1016/j.vaccine.2012.06.029 s27bp7ft 0.537387 Montefiori_2007, Schwartz_2007 Meng_2012, Zakhartchouk_2005, Cervantes-Barragan_2010, Mok_H_2012
11 Xiao_2011 A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen Xiao, Sa; Kumar, Manish; Yang, Xiuli; Akkoyunlu, Mustafa; Collins, Peter L.; Samal, Siba K.; Pal, Utpal 2011 2011-07-18 None N PMC3138909 21600949.0 10.1016/j.vaccine.2011.05.010 vr4c59hy 0.533249 Schwartz_2007, Lv_L_2014 Keshwara_2019
12 Lorin_2015 Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques Lorin, Clarisse; Vanloubbeeck, Yannick; Baudart, Sébastien; Ska, Michaël; Bayat, Babak; Brauers, Geoffroy; Clarinval, Géraldine; Donner, Marie-Noëlle; Marchand, Martine; Koutsoukos, Marguerite; Mettens, Pascal; Cohen, Joe; Voss, Gerald 2015 2015-04-09 COMM-USE N PMC4391709 25856308.0 10.1371/journal.pone.0122835 xaohrtq7 0.505593 Mazeike_2012 Bolton_2012, Azizi_2006, Busch_2020
13 White_2018 Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer White, Michael; Freistaedter, Andrew; Jones, Gwendolyn J. B.; Zervos, Emmanuel; Roper, Rachel L. 2018 2018-02-23 COMM-USE N PMC5825036 29474384.0 10.1371/journal.pone.0193131 fie121ns 0.498469
14 Matthews_2010 HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Perry, Brian A.; Tsuruta, Yuko; Komarova, Svetlana; Timares, Laura; Zhao, Chunxia; Makarova, Natalia; Borovjagin, Anton V.; Stewart, Phoebe L.; Wu, Hongju; Blackwell, Jerry L.; Curiel, David T. 2010 2010-07-27 COMM-USE N PMC2910733 20676400.0 10.1371/journal.pone.0011815 m4sp9sjn 0.495758 Montefiori_2007, Jiang_2006, Singh_2016 Hansra_2015, Peruzzi_2009
15 Bayer_2011 Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes Bayer, Wibke; Lietz, Ruth; Ontikatze, Teona; Johrden, Lena; Tenbusch, Matthias; Nabi, Ghulam; Schimmer, Simone; Groitl, Peter; Wolf, Hans; Berry, Cassandra M; Überla, Klaus; Dittmer, Ulf; Wildner, Oliver 2011 2011-09-26 COMM-USE N PMC3193818 21943056.0 10.1186/1742-4690-8-75 4mt2v3ip 0.491964 Jiang_2006, Montefiori_2007, Singh_2016 Mok_H_2012, Bolton_2012, Meng_2012
16 Meseda_2004 DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome Meseda, Clement A.; Schmeisser, Falko; Pedersen, Robin; Woerner, Amy; Weir, Jerry P. 2004 2004-01-05 PMC N 14972567.0 10.1016/j.virol.2003.09.033 mu4fdrel 0.483117
17 Wang_2010 Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines Wang, Zhongde; Martinez, Joy; Zhou, Wendi; La Rosa, Corinna; Srivastava, Tumul; Dasgupta, Anindya; Rawal, Ravindra; Li, Zhongqui; Britt, William J.; Diamond, Don 2010 2010-02-10 PMC N 19969118.0 10.1016/j.vaccine.2009.11.056 yw8gubcy 0.477085
18 Fausther-Bovendo_2014 Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what's important? Fausther-Bovendo, Hugues; Kobinger, Gary P 2014 2014-11-01 NONCOMM N PMC5443060 25483662.0 10.4161/hv.29594 3894l9qi 0.475906 Montefiori_2007, Singh_2016 Croyle_2008, Pandey_2012
19 Busch_2020 Measles Vaccines Designed for Enhanced CD8(+) T Cell Activation Busch, Elena; Kubon, Kristina D.; Mayer, Johanna K. M.; Pidelaserra-Martí, Gemma; Albert, Jessica; Hoyler, Birgit; Heidbuechel, Johannes P. W.; Stephenson, Kyle B.; Lichty, Brian D.; Osen, Wolfram; Eichmüller, Stefan B.; Jäger, Dirk; Ungerechts, Guy; Engeland, Christine E. 2020 2020-02-21 None N PMC7077255 32098134.0 10.3390/v12020242 270nzddu 0.467243 Montefiori_2007 Kim_S_2012, Cervantes-Barragan_2010, Mok_H_2012
20 Hansra_2015 Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion Hansra, Satyender; Pujhari, Sujit; Zakhartchouk, Alexander N 2015 2015-05-29 NONCOMM N PMC4460227 26069516.0 10.2174/1874357901509010001 p6ikd8ns 0.466283 Matthews_2010
21 Babiuk_2000 Adenoviruses as vectors for delivering vaccines to mucosal surfaces Babiuk, L.A; Tikoo, S.K 2000 2000-09-29 PMC N PMC7126179 11000466.0 10.1016/s0168-1656(00)00314-x 591iufv1 0.447938 Montefiori_2007 Tarahomjoo_2011, Tatsis_2004, Mühlebach_2016
22 Mühlebach_2016 Development of Recombinant Measles Virus-Based Vaccines Mühlebach, Michael D.; Hutzler, Stefan 2016 2016-11-26 PMC N PMC7121886 28374248.0 10.1007/978-1-4939-6869-5_9 cmbg0ty8 0.447755 Zuniga_2007, Mok_H_2012
23 Lin_C_2012 Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen Lin, Chen-Si; Kao, Shih-Han; Chen, Yu-Cheng; Li, Chi-Han; Hsieh, Yuan-Ting; Yang, Shang-Chih; Wu, Chang-Jer; Lee, Ru-Ping; Liao, Kuang-Wen 2012 2012-02-03 COMM-USE N PMC3298716 22304896.0 10.1186/1480-9222-14-2 gqqzekfk 0.437763 Azizi_2005, Montefiori_2007, Singh_2016 Li_W_2013
24 Bloom_2018 Immunization by Replication-Competent Controlled Herpesvirus Vectors Bloom, David C.; Tran, Robert K.; Feller, Joyce; Voellmy, Richard 2018 2018-07-31 COMM-USE N PMC6069180 29899091.0 10.1128/jvi.00616-18 tzq4i5xr 0.437112 Mühlebach_2016, Maunder_2015
25 Lawrence_2013 Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses Lawrence, Tessa M.; Wanjalla, Celestine N.; Gomme, Emily A.; Wirblich, Christoph; Gatt, Anthony; Carnero, Elena; García-Sastre, Adolfo; Lyles, Douglas S.; McGettigan, James P.; Schnell, Matthias J. 2013 2013-06-26 COMM-USE N PMC3694142 23840600.0 10.1371/journal.pone.0067123 wi7qdbc7 0.435406 Schwartz_2007, Montefiori_2007, Jiang_2006 Bolton_2012, Jiang_2006, Mok_H_2012
26 Bishop_1988 The release into the environment of genetically engineered viruses, vaccines and viral pesticides Bishop, David H.L. 1988 1988-04-30 PMC N 10.1016/0167-7799(88)90006-6 lke4y02f 0.428086 Bishop_1988
27 Thacker_2009 Strategies to overcome host immunity to adenovirus vectors in vaccine development Thacker, Erin E; Timares, Laura; Matthews, Qiana L 2009 2009-06-01 PMC N PMC3700409 19485756.0 10.1586/erv.09.29 7a6q4d3h 0.422274 Montefiori_2007, Mooney_2013 Borovjagin_2014, Tatsis_2004, Bangari_2006
28 Folegatti_2019 Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine Folegatti, Pedro M.; Bellamy, Duncan; Roberts, Rachel; Powlson, Jonathan; Edwards, Nick J.; Mair, Catherine F.; Bowyer, Georgina; Poulton, Ian; Mitton, Celia H.; Green, Nicky; Berrie, Eleanor; Lawrie, Alison M.; Hill, Adrian V.S.; Ewer, Katie J.; Hermon-Taylor, John; Gilbert, Sarah C. 2019 2019-05-15 COMM-USE N PMC6630572 31096710.0 10.3390/vaccines7020040 dgeisr8h 0.420425 Schwartz_2007, Montefiori_2007 Ploquin_2013, Warimwe_2013
29 Lopera-Madrid_2017 Safety and immunogenicity of mammalian cell derived and Modified Vaccinia Ankara vectored African swine fever subunit antigens in swine Lopera-Madrid, Jaime; Osorio, Jorge E.; He, Yongqun; Xiang, Zuoshuang; Adams, L. Garry; Laughlin, Richard C.; Mwangi, Waithaka; Subramanya, Sandesh; Neilan, John; Brake, David; Burrage, Thomas G.; Brown, William Clay; Clavijo, Alfonso; Bounpheng, Mangkey A. 2017 2017-03-31 PMC N PMC7112906 28241999.0 10.1016/j.vetimm.2017.01.004 bmrfz8pz 0.418540 Schwartz_2007 Meng_2012, Sawada_2011, Do_V_2020
30 Clarke_2006 Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector Clarke, David K.; Cooper, David; Egan, Michael A.; Hendry, R. Michael; Parks, Christopher L.; Udem, Stephen A. 2006 2006-09-15 PMC N PMC7079905 16977404.0 10.1007/s00281-006-0042-3 2sg1tlrg 0.409973 Schwartz_2007 Akahata_2010, Mok_H_2012, Jiang_2006, Keshwara_2019
31 Wyatt_2008 Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines Wyatt, Linda S.; Earl, Patricia L.; Vogt, Jennifer; Eller, Leigh Anne; Chandran, Dev; Liu, Jinyan; Robinson, Harriet L.; Moss, Bernard 2008 2008-01-01 PMC N PMC2262837 18155813.0 10.1016/j.vaccine.2007.11.036 zfuglf2e 0.383510 Jiang_2006 Hao_H_2008, Zhang_2011
32 Kim_S_2016 Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines Kim, Shin-Hee; Samal, Siba K. 2016 2016-07-04 COMM-USE N PMC4974518 27384578.0 10.3390/v8070183 axkdf5vu 0.383122 Schwartz_2007 Keshwara_2019, Akahata_2010
33 Huang_2005 A differential proteome in tumors suppressed by an adenovirus-based skin patch vaccine encoding human carcinoembryonic antigen Huang, Chun-Ming; Shi, Zhongkai; DeSilva, Tivanka S.; Yamamoto, Masato; Van Kampen, Kent R.; Elmets, Craig A.; Tang, De-chu C. 2005 2005-03-01 PMC N PMC3035721 15717328.0 10.1002/pmic.200401114 1x1bnt5j 0.381976 Hu_M_2007, Hao_H_2008 Hao_H_2008
34 Jiang_2006 Elicitation of neutralizing antibodies by intranasal administration of recombinant vesicular stomatitis virus expressing human immunodeficiency virus type 1 gp120 Jiang, Pengfei; Liu, Yanxia; Yin, Xiaolei; Yuan, Fei; Nie, YuChun; Luo, Min; Aihua, Zheng; Liyin, Du; Ding, Mingxiao; Deng, Hongkui 2006 2006-01-13 PMC N PMC7092882 16313884.0 10.1016/j.bbrc.2005.11.067 vct6xakc 0.380656 Schwartz_2007 Mok_H_2012, Azizi_2006, Clarke_2006
35 Fedosyuk_2019 Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components Fedosyuk, Sofiya; Merritt, Thomas; Peralta-Alvarez, Marco Polo; Morris, Susan J; Lam, Ada; Laroudie, Nicolas; Kangokar, Anilkumar; Wright, Daniel; Warimwe, George M; Angell-Manning, Phillip; Ritchie, Adam J; Gilbert, Sarah C; Xenopoulos, Alex; Boumlic, Anissa; Douglas, Alexander D 2019 2019-11-08 None N PMC6949866 31047679.0 10.1016/j.vaccine.2019.04.056 u8y47qmd 0.375573 Kopecky-Bromberg_2009, Tripp_2014 Bangari_2006, Tatsis_2004, Hammond_2005
36 Singh_2016 Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines Singh, Shakti; Vedi, Satish; Samrat, Subodh Kumar; Li, Wen; Kumar, Rakesh; Agrawal, Babita 2016 2016-01-11 COMM-USE N PMC4709057 26751211.0 10.1371/journal.pone.0146404 hrfbygub 0.359073 Montefiori_2007 Mok_H_2012, Akahata_2010
37 Tatsis_2004 Adenoviruses as vaccine vectors Tatsis, Nia; Ertl, Hildegund C.J. 2004 2004-10-31 PMC N PMC7106330 15451446.0 10.1016/j.ymthe.2004.07.013 aw8p35c5 0.354678 Montefiori_2007, Bangari_2006 Bangari_2006, Singh_2016, Borovjagin_2014, Mittal_2016
38 Hammond_2005 Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics Hammond, Jef M.; Johnson, Michael A. 2005 2005-01-31 PMC N PMC7128824 15683761.0 10.1016/j.tvjl.2003.09.007 489dpefx 0.345603 Kim_S_2016
39 Saxena_2013 Pre-existing immunity against vaccine vectors – friend or foe? Saxena, Manvendra; Van, Thi Thu Hao; Baird, Fiona J.; Coloe, Peter J.; Smooker, Peter M. 2013 2013-01-23 COMM-USE N PMC3542731 23175507.0 10.1099/mic.0.049601-0 v812zn3r 0.344349 Montefiori_2007, Tripp_2014 Tarahomjoo_2011, Singh_2016, Meseda_2016
40 Anraku_2008 Kunjin replicon-based simian immunodeficiency virus gag vaccines Anraku, Itaru; Mokhonov, Vladislav V.; Rattanasena, Paweena; Mokhonova, Ekaterina I.; Leung, Jason; Pijlman, Gorben; Cara, Andrea; Schroder, Wayne A.; Khromykh, Alexander A.; Suhrbier, Andreas 2008 2008-06-19 PMC N PMC7115363 18462846.0 10.1016/j.vaccine.2008.04.001 de0b27nq 0.340714 Dahiya_2012
41 Callendret_2007 Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS Callendret, Benoît; Lorin, Valérie; Charneau, Pierre; Marianneau, Philippe; Contamin, Hugues; Betton, Jean-Michel; van der Werf, Sylvie; Escriou, Nicolas 2007 2007-07-05 PMC N PMC7103356 17331558.0 10.1016/j.virol.2007.01.012 7del8d2p 0.328733 Liu_R_2005, Escriou_2014
42 Ohtsuka_2019 A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vector Ohtsuka, Junpei; Fukumura, Masayuki; Furuyama, Wakako; Wang, Shujie; Hara, Kenichiro; Maeda, Mitsuyo; Tsurudome, Masato; Miyamoto, Hiroko; Kaito, Aika; Tsuda, Nobuyuki; Kataoka, Yosky; Mizoguchi, Akira; Takada, Ayato; Nosaka, Tetsuya 2019 2019-09-09 COMM-USE N PMC6733870 31501502.0 10.1038/s41598-019-49579-y dqvgng2s 0.328249 Jiang_2006, Schwartz_2007 Hao_H_2008, Chen_2007
43 Nakayama_2016 Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens Nakayama, Tetsuo; Sawada, Akihito; Yamaji, Yoshiaki; Ito, Takashi 2016 2016-01-04 PMC N PMC7115616 26562316.0 10.1016/j.vaccine.2015.10.127 4vkag60z 0.325056 Mooney_2013 Sawada_2011, Mühlebach_2016, Mok_H_2012
44 Luke_2010 Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers Luke, J M; Vincent, J M; Du, S X; Gerdemann, U; Leen, A M; Whalen, R G; Hodgson, C P; Williams, J A 2010 2010-11-25 PMC N PMC7091570 21107439.0 10.1038/gt.2010.149 tjvjlyn9 0.320161
45 Zhang_2016 Adenoviral vector-based strategies against infectious disease and cancer Zhang, Chao; Zhou, Dongming 2016 2016-04-22 NONCOMM N PMC4994731 27105067.0 10.1080/21645515.2016.1165908 a3nzj6yh 0.305064 Montefiori_2007, Tatsis_2004, Mooney_2013 Tatsis_2004, Borovjagin_2014, Ertl_2016
46 Patel_2010 A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model Patel, Ami; Tikoo, Suresh; Kobinger, Gary 2010 2010-12-16 COMM-USE N PMC3002947 21179494.0 10.1371/journal.pone.0015301 l3ej1hdk 0.304688 Schwartz_2007 Meng_2012, Warimwe_2013, Wu_P_2017
47 Hangalapura_2012 CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic Hangalapura, Basav N.; Timares, Laura; Oosterhoff, Dinja; Scheper, Rik J.; Curiel, David T.; de Gruijl, Tanja D. 2012 2012-06-01 PMC N PMC3433169 22228547.0 10.1002/jgm.1648 7mi07qm9 0.304020 Montefiori_2007 Garu_2016, Cervantes-Barragan_2010
48 Liniger_2008 Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses Liniger, Matthias; Zuniga, Armando; Tamin, Azaibi; Azzouz-Morin, Teldja N.; Knuchel, Marlyse; Marty, Rene R.; Wiegand, Marian; Weibel, Sara; Kelvin, David; Rota, Paul A.; Naim, Hussein Y. 2008 2008-04-16 PMC N PMC7115634 18346823.0 10.1016/j.vaccine.2008.01.057 tbp3it7r 0.300148 Schwartz_2007, Lv_L_2014 Escriou_2014